► Customized research for IMUX vs. APOP!
► All in one page research, scroll down. Compare two other stocks.
► Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.
Done! Side by Side Research Below for IMUX vs. APOP.
↗ Join Our Free Email Newsletter.
► Immunic Inc. vs. Cellect Biotechnology Ltd.
Industry Match! Industry of Both IMUX and APOP:
Health Care/Life Sciences
IMUX
Data Last Updated: More than 1 mo ago
↻ Update Column 1 to Most Recent
► Key Statistics
Cap: 87.713M
P/E: N/A
P/S: N/A
Q P/B: 1.26
Y Rev: -
Q Rev: -
Beta: 2.48

IMUX Share Stats
► Outstanding Shares
9.99M
► Float Shares
3.11M
► Percent of Float Short
0.40%
IMUX Insider Stats
► Percent Outstanding Insider Ownership
N/A
► Percent Outstanding Institution Ownership
N/A
IMUX Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share IMUX Insights
IMUX Profile
► CEO
Dr. Duane D. Nash
► Exchange
Nasdaq
► Employees
10.00
► About
Immunic, Inc. engages in developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products...

IMUX Financials
Annual Financials
Income Statement
► Revenue
-
► Net Income
(41.48M)
Cash Flow Statement
► Change in Cash / Investments
(43.58M)
Balance Sheet
► Cash / Investments
13.32M
► Short Term Debt
None
► Long Term Debt
None
► Total Current Assets
14.23M
► Total Current Liabilities
2.51M
► Total Assets
14.98M
► Total Liabilities
2.55M
► Stockholder Equity
12.43M
Quarterly Financials
Income Statement
► Q Revenue
-
► Q Net Income
(14.71M)
Cash Flow Statement
► Q Change in Cash / Investments
26.78M
Balance Sheet
► Q Cash / Investments
36.12M
► Q Short Term Debt
None
► Q Long Term Debt
None
► Q Total Current Assets
39.49M
► Q Total Current Liabilities
3.12M
► Q Total Assets
72.57M
► Q Total Liabilities
3.16M
► Q Stockholder Equity
69.41M

IMUX Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

APOP
Data Last Updated: More than 2 wks ago
↻ Update Column 2 to Most Recent
► Key Statistics
Cap: 314,214
P/E: N/A
P/S: N/A
Q P/B: 0
Y Rev: -
Q Rev: -
Beta: 1.85

APOP Share Stats
► Outstanding Shares
5.60M
► Float Shares
N/A
► Percent of Float Short
N/A
APOP Insider Stats
► Percent Outstanding Insider Ownership
N/A
► Percent Outstanding Institution Ownership
N/A
APOP Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share APOP Insights
APOP Profile
► CEO
Mr. Kasbian Nuriel Chirich
► Exchange
Nasdaq
► Employees
28.00
► About
Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which...

APOP Financials
Annual Financials
Income Statement
► Revenue
-
► Net Income
(5.59M)
Cash Flow Statement
► Change in Cash / Investments
1.13M
Balance Sheet
► Cash / Investments
4.77M
► Short Term Debt
None
► Long Term Debt
None
► Total Current Assets
4.98M
► Total Current Liabilities
1.31M
► Total Assets
5.52M
► Total Liabilities
1.8M
► Stockholder Equity
3.73M
Quarterly Financials
Income Statement
► Q Revenue
-
► Q Net Income
(227,021)
Cash Flow Statement
► Q Change in Cash / Investments
(2.07M)
Balance Sheet
► Q Cash / Investments
7.64M
► Q Short Term Debt
None
► Q Long Term Debt
None
► Q Total Current Assets
7.83M
► Q Total Current Liabilities
1.3M
► Q Total Assets
8.73M
► Q Total Liabilities
2.59M
► Q Stockholder Equity
6.14M

APOP Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

